Alexion Pharmaceuticals, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/13/2021

Shares

28,593

Value ($000)

5,253

Weight

0.0%

2013 Q4 - 2021 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/13/2021	5,253	0.0%	28,593	6/30/2021
2021 Q1	5/28/2021	3,885	0.0%	25,408	3/31/2021
2020 Q4	2/16/2021	15,305	0.0%	97,955	12/31/2020
2020 Q3	11/13/2020	16,108	0.0%	144,403	9/30/2020
2020 Q2	8/13/2020	12,275	0.0%	109,365	6/30/2020
2020 Q1	5/15/2020	23,679	0.1%	246,890	3/31/2020
2019 Q4	2/11/2020	34,812	0.1%	321,885	12/31/2019
2014 Q1	5/15/2014	3,733	0.0%	24,539	3/31/2014
2013 Q4	2/14/2014	2,158	0.0%	16,239	12/31/2013